Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease
Open Access
- 27 November 2006
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 203 (13) , 2785-2791
Abstract
To explore the interactions between regulatory T cells and pathogenic effector cytokines, we have developed a model of a T cell–mediated systemic autoimmune disorder resembling graft-versus-host disease. The cytokine responsible for tissue inflammation in this disorder is interleukin (IL)-17, whereas interferon (IFN)-γ produced by Th1 cells has a protective effect in this setting. Because of the interest in potential therapeutic approaches utilizing transfer of regulatory T cells and inhibition of the IL-2 pathway, we have explored the roles of these in the systemic disease. We demonstrate that the production of IL-17 and tissue infiltration by IL-17–producing cells occur and are even enhanced in the absence of IL-2. Regulatory T cells favor IL-17 production but prevent the disease when administered early in the course by suppressing expansion of T cells. Thus, the pathogenic or protective effects of cytokines and the therapeutic capacity of regulatory T cells are crucially dependent on the timing and the nature of the disease.Keywords
This publication has 29 references indexed in Scilit:
- Transforming growth factor-β induces development of the TH17 lineageNature, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T CellsImmunity, 2006
- Understanding the IL-23–IL-17 immune pathwayTrends in Immunology, 2006
- Sequential development of interleukin 2–dependent effector and regulatory T cells in response to endogenous systemic antigenJournal of Experimental Medicine, 2005
- A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17Nature Immunology, 2005
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005
- Anti-TNF therapy: Where have we got to in 2005?Journal of Autoimmunity, 2005
- Interleukin-17 Family Members and InflammationImmunity, 2004
- NaturallyArisingCD4+RegulatoryT Cells forImmunologicSelf-Tolerance andNegativeControl ofImmuneResponsesAnnual Review of Immunology, 2004